Exact Mass: 475.3145

Exact Mass Matches: 475.3145

Found 285 metabolites which its exact mass value is equals to given mass value 475.3145, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Netilmicin

(2R,3R,4R,5R)-2-{[(1S,2S,3R,4S,6R)-4-amino-3-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-6-(ethylamino)-2-hydroxycyclohexyl]oxy}-3-methyl-4-(methylamino)oxane-3,5-diol

C21H41N5O7 (475.3006)


Netilmicin is a semisynthetic 1-N-ethyl derivative of sisomycin, an aminoglycoside antibiotic with action similar to gentamicin, but less ear and kidney toxicity. [PubChem] Netilmicin inhibits protein synthesis in susceptible organisms by binding to the bacterial 30S ribosomal subunit and interfering with mRNA binding and the acceptor tRNA site. The bactericidal effect of netilmiicin is not fully understood. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D005839 - Gentamicins C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D004791 - Enzyme Inhibitors > D011500 - Protein Synthesis Inhibitors C254 - Anti-Infective Agent > C258 - Antibiotic

   

Marckine

1H-Pyrido[3,4-b]indol-6-ol, 1-[[(2S,3R,11bS)-3-ethyl-1,3,4,6,7,11b-hexahydro- 9,10-dimethoxy-2H-benzo[a]quinolizin-2-yl]methyl]- 2,3,4,9-tetrahydro-, (1R)-

C29H37N3O3 (475.2835)


   

Alangimarckine

Alangimarckine

C29H37N3O3 (475.2835)


A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 as well as a hydroxy group at position 9.

   

Progeldanamycin

Progeldanamycin

C27H41NO6 (475.2934)


   

Ulipristal acetate

Ulipristal acetate

C30H37NO4 (475.2722)


A 20-oxo steroid obtained by acetylation of the 17-hydroxy group of (11beta,17alpha)-17-acetyl-11-[4-(dimethylamino)phenyl]-3-oxoestra-4,9-dien-17-ol (ulipristal). A selective progesterone receptor modulator, which is employed as an emergency contraceptive. C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist > C1891 - Progesterone Antagonist D012102 - Reproductive Control Agents > D003270 - Contraceptive Agents

   

LysoPE(0:0/18:3(9Z,12Z,15Z))

(2-aminoethoxy)[(2R)-3-hydroxy-2-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphinic acid

C23H42NO7P (475.2699)


LysoPE(0:0/18:3(9Z,12Z,15Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/18:3(9Z,12Z,15Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

LysoPE(0:0/18:3(6Z,9Z,12Z))

(2-aminoethoxy)[(2R)-3-hydroxy-2-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxy]phosphinic acid

C23H42NO7P (475.2699)


LysoPE(0:0/18:3(6Z,9Z,12Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/18:3(6Z,9Z,12Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

LysoPE(18:3(6Z,9Z,12Z)/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-[(6Z,9Z,12Z)-octadeca-6,9,12-trienoyloxy]propoxy]phosphinic acid

C23H42NO7P (475.2699)


LysoPE(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(18:3(6Z,9Z,12Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

Hydrocortamate

2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-6-en-14-yl]-2-oxoethyl 2-(diethylamino)acetate

C27H41NO6 (475.2934)


Hydrocortamate is a synthetic glucocorticoid used for its anti-inflammatory or immunosuppressive properties to treat inflammation due to corticosteroid-responsive dermatoses. Glucocorticoids are a class of steroid hormones characterised by an ability to bind with the cortisol receptor and trigger a variety of important cardiovascular, metabolic, immunologic and homeostatic effects. C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

LysoPE(18:3(9Z,12Z,15Z)/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphinic acid

C23H42NO7P (475.2699)


LysoPE(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(18:3(9Z,12Z,15Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.

   

N-Docosahexaenoyl phenylalanine

(2S)-2-{[(4Z,7Z,10Z,13Z,16Z,19Z)-1-hydroxydocosa-4,7,10,13,16,19-hexaen-1-ylidene]amino}-3-phenylpropanoic acid

C31H41NO3 (475.3086)


N-docosahexaenoyl phenylalanine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Phenylalanine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl phenylalanine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl phenylalanine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

Z-Leu-leu-leu-al

2-[(2-{[(benzyloxy)(hydroxy)methylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-4-methyl-N-(4-methyl-1-oxopentan-2-yl)pentanimidate

C26H41N3O5 (475.3046)


   

Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate

Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamic acid

C26H41N3O5 (475.3046)


   

Ulipristal acetate

[(8s,11r,13s,14s,17r)-17-Acetyl-11-[4-(Dimethylamino)phenyl]-13-Methyl-3-Oxo-1,2,6,7,8,11,12,14,15,16-Decahydrocyclopenta[a]phenanthren-17-Yl] Acetate

C30H37NO4 (475.2722)


   

Z-LLNle-CHO

2-[(2-{[(benzyloxy)(hydroxy)methylidene]amino}-1-hydroxy-4-methylpentylidene)amino]-4-methyl-N-(1-oxohexan-2-yl)pentanimidate

C26H41N3O5 (475.3046)


   

Epothilone H2

Epothilone H2

C27H41NO6 (475.2934)


   

Holantosine F

Holantosine F

C28H45NO5 (475.3298)


   

10,11-dimethoxy-tubolosan-9-ol|Alangimarckin

10,11-dimethoxy-tubolosan-9-ol|Alangimarckin

C29H37N3O3 (475.2835)


   
   

6鈥樎?N-Methylverdamicin

6鈥樎?N-Methylverdamicin

C21H41N5O7 (475.3006)


   

kleinhospitine A

kleinhospitine A

C30H37NO4 (475.2722)


   
   
   

Ulipristal

Ulipristal acetate

C30H37NO4 (475.2722)


   

C27H41NO6_(7E)-11-Hydroxy-3-isobutyl-4,5,8,13,13-pentamethyl-3,3a,4,6a,9,10,11,11a,14a,15-decahydro-1H-[1,3]dioxolo[9,10]oxacyclododecino[2,3-d]isoindole-1,16(2H)-dione

NCGC00381131-01_C27H41NO6_(7E)-11-Hydroxy-3-isobutyl-4,5,8,13,13-pentamethyl-3,3a,4,6a,9,10,11,11a,14a,15-decahydro-1H-[1,3]dioxolo[9,10]oxacyclododecino[2,3-d]isoindole-1,16(2H)-dione

C27H41NO6 (475.2934)


   

LPE 18:3

2-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphoethanolamine

C23H42NO7P (475.2699)


Annotation level-3

   

Cys Ile Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Cys Ile Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Ile Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Ile Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-methylpentanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Cys Lys Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Lys Ile Leu

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Lys Leu Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Lys Leu Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Leu Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Cys Leu Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Leu Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Cys Leu Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-4-methylpentanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Ile Cys Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Ile Cys Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Ile Cys Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Ile Cys Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-sulfanylpropanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Ile Ile Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]-3-sulfanylpropanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Ile Ile Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylpentanamido]hexanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Ile Lys Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Ile Lys Cys Leu

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Ile Lys Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Ile Lys Leu Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Ile Leu Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]-3-sulfanylpropanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Ile Leu Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-methylpentanamido]hexanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Ile Arg Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Ile Arg Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Ile Ser Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Ile Ser Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Ile Thr Arg Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Ile Thr Ser Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Lys Cys Ile Ile

(2S,3S)-2-[(2S,3S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Cys Ile Leu

(2S)-2-[(2S,3S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Cys Leu Ile

(2S,3S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-4-methylpentanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Cys Leu Leu

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-4-methylpentanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Ile Cys Ile

(2S,3S)-2-[(2R)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Ile Cys Leu

(2S)-2-[(2R)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Ile Ile Cys

(2R)-2-[(2S,3S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Lys Ile Leu Cys

(2R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Lys Lys Asn Ser

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Lys Lys Ser Asn

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C19H37N7O7 (475.2754)


   

Lys Leu Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Leu Cys Leu

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Lys Leu Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Lys Leu Leu Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Lys Met Val Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-(methylsulfanyl)butanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H41N5O5S (475.2828)


   

Lys Asn Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]hexanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Lys Asn Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-hydroxypropanamido]hexanoic acid

C19H37N7O7 (475.2754)


   

Lys Ser Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]hexanamido]-3-carbamoylpropanoic acid

C19H37N7O7 (475.2754)


   

Lys Ser Asn Lys

(2S)-6-amino-2-[(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-hydroxypropanamido]propanamido]hexanoic acid

C19H37N7O7 (475.2754)


   

Lys Val Met Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-4-(methylsulfanyl)butanamido]-3-methylbutanoic acid

C21H41N5O5S (475.2828)


   

Lys Val Val Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-methylbutanamido]-3-methylbutanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O5S (475.2828)


   

Leu Cys Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-3-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Leu Cys Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]hexanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Leu Cys Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]hexanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Leu Cys Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-4-methylpentanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Leu Ile Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]-3-sulfanylpropanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Leu Ile Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylpentanamido]hexanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Leu Lys Cys Ile

(2S,3S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-sulfanylpropanamido]-3-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Leu Lys Cys Leu

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-sulfanylpropanamido]-4-methylpentanoic acid

C21H41N5O5S (475.2828)


   

Leu Lys Ile Cys

(2R)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-3-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Leu Lys Leu Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]-4-methylpentanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Leu Leu Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]-3-sulfanylpropanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Leu Leu Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-methylpentanamido]hexanamido]-3-sulfanylpropanoic acid

C21H41N5O5S (475.2828)


   

Leu Arg Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Leu Arg Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Leu Ser Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Leu Ser Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Leu Thr Arg Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Leu Thr Ser Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Met Lys Val Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]hexanamido]-3-methylbutanamido]-3-methylbutanoic acid

C21H41N5O5S (475.2828)


   

Met Val Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylbutanamido]hexanamido]-3-methylbutanoic acid

C21H41N5O5S (475.2828)


   

Met Val Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylbutanamido]-3-methylbutanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Asn Lys Lys Ser

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]hexanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Asn Lys Ser Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-carbamoylpropanamido]hexanamido]-3-hydroxypropanamido]hexanoic acid

C19H37N7O7 (475.2754)


   

Asn Ser Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]hexanamido]hexanoic acid

C19H37N7O7 (475.2754)


   

Arg Ile Ser Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Arg Ile Thr Ser

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Arg Leu Ser Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Arg Leu Thr Ser

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxybutanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Arg Ser Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Arg Ser Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Arg Ser Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Arg Ser Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Arg Thr Ile Ser

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Arg Thr Leu Ser

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Arg Thr Ser Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Arg Thr Ser Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Arg Thr Thr Val

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C19H37N7O7 (475.2754)


   

Arg Thr Val Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Arg Val Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Ser Ile Arg Thr

(2S,3R)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Ser Ile Thr Arg

(2S)-2-[(2S,3R)-2-[(2S,3S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Ser Lys Lys Asn

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]hexanamido]-3-carbamoylpropanoic acid

C19H37N7O7 (475.2754)


   

Ser Lys Asn Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-hydroxypropanamido]hexanamido]-3-carbamoylpropanamido]hexanoic acid

C19H37N7O7 (475.2754)


   

Ser Leu Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Ser Leu Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-4-methylpentanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Ser Asn Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]hexanamido]hexanoic acid

C19H37N7O7 (475.2754)


   

Ser Arg Ile Thr

(2S,3R)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Ser Arg Leu Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Ser Arg Thr Ile

(2S,3S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Ser Arg Thr Leu

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Ser Thr Ile Arg

(2S)-2-[(2S,3S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Ser Thr Leu Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Ser Thr Arg Ile

(2S,3S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Ser Thr Arg Leu

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Thr Ile Arg Ser

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Thr Ile Ser Arg

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Thr Leu Arg Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Thr Leu Ser Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-methylpentanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Thr Arg Ile Ser

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylpentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Thr Arg Leu Ser

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-methylpentanamido]-3-hydroxypropanoic acid

C19H37N7O7 (475.2754)


   

Thr Arg Ser Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-3-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Thr Arg Ser Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxypropanamido]-4-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Thr Arg Thr Val

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-methylbutanoic acid

C19H37N7O7 (475.2754)


   

Thr Arg Val Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Thr Ser Ile Arg

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-3-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Thr Ser Leu Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-4-methylpentanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Thr Ser Arg Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-3-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Thr Ser Arg Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxypropanamido]-5-carbamimidamidopentanamido]-4-methylpentanoic acid

C19H37N7O7 (475.2754)


   

Thr Thr Arg Val

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-methylbutanoic acid

C19H37N7O7 (475.2754)


   

Thr Thr Val Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Thr Val Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Thr Val Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Val Lys Met Val

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-4-(methylsulfanyl)butanamido]-3-methylbutanoic acid

C21H41N5O5S (475.2828)


   

Val Lys Val Met

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-methylbutanamido]hexanamido]-3-methylbutanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O5S (475.2828)


   

Val Met Lys Val

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-(methylsulfanyl)butanamido]hexanamido]-3-methylbutanoic acid

C21H41N5O5S (475.2828)


   

Val Met Val Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-(methylsulfanyl)butanamido]-3-methylbutanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

Val Arg Thr Thr

(2S,3R)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Val Thr Arg Thr

(2S,3R)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C19H37N7O7 (475.2754)


   

Val Thr Thr Arg

(2S)-2-[(2S,3R)-2-[(2S,3R)-2-[(2S)-2-amino-3-methylbutanamido]-3-hydroxybutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C19H37N7O7 (475.2754)


   

Val Val Lys Met

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]hexanamido]-4-(methylsulfanyl)butanoic acid

C21H41N5O5S (475.2828)


   

Val Val Met Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylbutanamido]-4-(methylsulfanyl)butanamido]hexanoic acid

C21H41N5O5S (475.2828)


   

MG-132

Benzyl n-[(2s)-4-methyl-1-[[(2r)-4-methyl-1-[[(2s)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate

C26H41N3O5 (475.3046)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015853 - Cysteine Proteinase Inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2160 - Proteasome Inhibitor D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D007976 - Leupeptins D000970 - Antineoplastic Agents C471 - Enzyme Inhibitor

   

(R)-MG132

N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1R)-1-formyl-3-methylbutyl]-L-leucinamide

C26H41N3O5 (475.3046)


   

LPE(18:3)

1-alpha-Linolenoyl-2-hydroxy-sn-glycero-3-phosphoethanolamine

C23H42NO7P (475.2699)


   

N-docosahexaenoyl phenylalanine

N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-phenylalanine

C31H41NO3 (475.3086)


   

PE(18:3(6Z,9Z,12Z)/0:0)

1-(6Z,9Z,12Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

C23H42NO7P (475.2699)


   

LysoPE(18:3/0:0)

(2-aminoethoxy)[(2R)-2-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoyloxy]propoxy]phosphinic acid

C23H42NO7P (475.2699)


   

hydrocortamate

2-[(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-2,15-dimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-14-yl]-2-oxoethyl 2-(diethylamino)acetate

C27H41NO6 (475.2934)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid

   

NA 31:11;O2

N-(4Z,7Z,10Z,12E,16Z,19Z-docosahexaenoyl)-phenylalanine

C31H41NO3 (475.3086)


   

Longichalasin B

Longichalasin B

C30H37NO4 (475.2722)


   

1-[[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl]-propan-2-ylamino]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

1-[[2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl]-propan-2-ylamino]-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol

C27H41NO6 (475.2934)


   

2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester

2-{4-[N-(5,6-diphenylpyrazin-2-yl)-N-isopropylamino]butyloxy}acetic acid tert-butyl ester

C29H37N3O3 (475.2835)


   

Dinoprost

Dinoprost Tromethamine

C24H45NO8 (475.3145)


D012102 - Reproductive Control Agents > D000019 - Abortifacient Agents D012102 - Reproductive Control Agents > D010120 - Oxytocics C78568 - Prostaglandin Analogue

   

triethanolammonium dodecylbenzene sulfonate

triethanolammonium dodecylbenzene sulfonate

C24H45NO6S (475.2967)


   

3-Pyridinemethanol, 4-[4-fluoro-2-(phenylmethoxy)phenyl]-a-methyl-2,6-bis(1-methylethyl)-5-(1-penten-1-yl)-

3-Pyridinemethanol, 4-[4-fluoro-2-(phenylmethoxy)phenyl]-a-methyl-2,6-bis(1-methylethyl)-5-(1-penten-1-yl)-

C31H38FNO2 (475.2886)


   

1-HYDROXY-N-[4-(2,4-DI-TERT-PENTYLPHENOXY)BUTYL]-2-NAPHTHAMIDE

1-HYDROXY-N-[4-(2,4-DI-TERT-PENTYLPHENOXY)BUTYL]-2-NAPHTHAMIDE

C31H41NO3 (475.3086)


   

Z-Leu-Leu-Nle-aldehyde

benzyl N-[4-methyl-1-[[4-methyl-1-oxo-1-(1-oxohexan-2-ylamino)pentan-2-yl]amino]-1-oxopentan-2-yl]carbamate

C26H41N3O5 (475.3046)


D004791 - Enzyme Inhibitors > D000091062 - Gamma Secretase Inhibitors and Modulators Z-LLNle-CHO (Z-Leu-Leu-Nle-CHO) is a γ-secretase inhibitor I. Z-LLNle-CHO induces caspase and ROS-dependent apoptosis by blocking the Akt-mediated pro-survival pathway. Z-LLNle-CHO can be used in cancer research, such as breast cancer and leukaemia[1][2].

   

2(3H)-Furanone, 5-hexyldihydro-4-methyl-, mixt. with 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride (1:1)

2(3H)-Furanone, 5-hexyldihydro-4-methyl-, mixt. with 2-(diphenylmethoxy)-N,N-dimethylethanamine hydrochloride (1:1)

C28H42ClNO3 (475.2853)


   

1-HYDROXY-N-(2-TETRADECYLOXYPHENYL)-2-NAPHTHALENECARBOXAMIDE

1-HYDROXY-N-(2-TETRADECYLOXYPHENYL)-2-NAPHTHALENECARBOXAMIDE

C31H41NO3 (475.3086)


   

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] octadeca-6,9,12-trienoate

[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] octadeca-6,9,12-trienoate

C23H42NO7P (475.2699)


   

1-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphoethanolamine

1-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phosphoethanolamine

C23H42NO7P (475.2699)


   

(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4-amino-3-[[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-6-(ethylamino)-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol

C21H41N5O7 (475.3006)


   

Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate

Benzyl N-[(2S)-2-[[(2S)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]-N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate

C26H41N3O5 (475.3046)


   

N-hexanoylsphingosine 1-phosphate(2-)

N-hexanoylsphingosine 1-phosphate(2-)

C24H46NO6P-2 (475.3063)


   

[(8S,11R,13S,14S,17S)-17-Acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate

[(8S,11R,13S,14S,17S)-17-Acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate

C30H37NO4 (475.2722)


   

N-[4-methyl-1-[[4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamic acid (phenylmethyl) ester

N-[4-methyl-1-[[4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamic acid (phenylmethyl) ester

C26H41N3O5 (475.3046)


   

N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4S,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

(8R,9R,10R)-10-(hydroxymethyl)-N-(4-methoxyphenyl)-9-[4-(4-methylpent-1-ynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

(8R,9R,10R)-10-(hydroxymethyl)-N-(4-methoxyphenyl)-9-[4-(4-methylpent-1-ynyl)phenyl]-1,6-diazabicyclo[6.2.0]decane-6-carboxamide

C29H37N3O3 (475.2835)


   

2-[(3R,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(3-morpholin-4-ylpropyl)acetamide

2-[(3R,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-(3-morpholin-4-ylpropyl)acetamide

C25H37N3O6 (475.2682)


   

2-[(3S,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

2-[(3S,6aR,8S,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

C25H37N3O6 (475.2682)


   

2-[(3R,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

2-[(3R,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

C25H37N3O6 (475.2682)


   

N-[(5S,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5S,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C25H37N3O6 (475.2682)


   

N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4R,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

N-[(5S,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5S,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C25H37N3O6 (475.2682)


   

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H41N3O5 (475.3046)


   

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H41N3O5 (475.3046)


   

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H41N3O5 (475.3046)


   

2-[(3R,6aR,8R,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

2-[(3R,6aR,8R,10aR)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

C25H37N3O6 (475.2682)


   

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C26H41N3O5 (475.3046)


   

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C26H41N3O5 (475.3046)


   

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C26H41N3O5 (475.3046)


   

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C26H41N3O5 (475.3046)


   

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C26H41N3O5 (475.3046)


   

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-4-oxanecarboxamide

C26H41N3O5 (475.3046)


   

N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4S,7R,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

N-[(5R,6S,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5R,6S,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C25H37N3O6 (475.2682)


   

N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4S,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4R,7S,8R)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

N-[(5R,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5R,6R,9R)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C25H37N3O6 (475.2682)


   

N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4S,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

N-[(5R,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5R,6R,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C25H37N3O6 (475.2682)


   

N-[(5S,6S,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

N-[(5S,6S,9S)-8-(2-cyclopropyl-1-oxoethyl)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-methoxyacetamide

C25H37N3O6 (475.2682)


   

N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4R,7S,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

N-[(4R,7R,8S)-8-methoxy-5-(2-methoxy-1-oxoethyl)-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]cyclobutanecarboxamide

C25H37N3O6 (475.2682)


   

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H41N3O5 (475.3046)


   

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H41N3O5 (475.3046)


   

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H41N3O5 (475.3046)


   

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-(4-oxanylmethyl)-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]propanamide

C26H41N3O5 (475.3046)


   

2-[(3S,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

2-[(3S,6aS,8R,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

C25H37N3O6 (475.2682)


   

2-[(3S,6aS,8S,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

2-[(3S,6aS,8S,10aS)-1-benzoyl-3-hydroxy-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[3-(4-morpholinyl)propyl]acetamide

C25H37N3O6 (475.2682)


   

2-amino-2-methoxypropane-1,3-diol;(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid

2-amino-2-methoxypropane-1,3-diol;(E)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxyoct-1-enyl]cyclopentyl]hept-5-enoic acid

C24H45NO8 (475.3145)


   
   

HexCer 9:1;2O/9:0

HexCer 9:1;2O/9:0

C24H45NO8 (475.3145)


   

HexCer 11:1;2O/7:0

HexCer 11:1;2O/7:0

C24H45NO8 (475.3145)


   

HexCer 10:1;2O/8:0

HexCer 10:1;2O/8:0

C24H45NO8 (475.3145)


   

HexCer 16:1;2O/2:0

HexCer 16:1;2O/2:0

C24H45NO8 (475.3145)


   

HexCer 13:1;2O/5:0

HexCer 13:1;2O/5:0

C24H45NO8 (475.3145)


   

HexCer 12:1;2O/6:0

HexCer 12:1;2O/6:0

C24H45NO8 (475.3145)


   

HexCer 8:1;2O/10:0

HexCer 8:1;2O/10:0

C24H45NO8 (475.3145)


   

HexCer 15:1;2O/3:0

HexCer 15:1;2O/3:0

C24H45NO8 (475.3145)


   

HexCer 14:1;2O/4:0

HexCer 14:1;2O/4:0

C24H45NO8 (475.3145)


   

NAGly 16:4/10:0

NAGly 16:4/10:0

C28H45NO5 (475.3298)


   

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

[3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-2-hydroxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

C24H46NO6P (475.3063)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]dec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxytetradec-9-enoyl]amino]dec-4-ene-1-sulfonic acid

C24H45NO6S (475.2967)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] acetate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]propan-2-yl] acetate

C23H42NO7P (475.2699)


   

(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)dodeca-4,8-diene-1-sulfonic acid

(4E,8E)-3-hydroxy-2-(2-hydroxydodecanoylamino)dodeca-4,8-diene-1-sulfonic acid

C24H45NO6S (475.2967)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]dodec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxydodec-5-enoyl]amino]dodec-4-ene-1-sulfonic acid

C24H45NO6S (475.2967)


   

(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]undec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-[[(Z)-2-hydroxytridec-8-enoyl]amino]undec-4-ene-1-sulfonic acid

C24H45NO6S (475.2967)


   

(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(tridecanoylamino)dodec-4-ene-1-sulfonic acid

C25H49NO5S (475.3331)


   

3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-tetradec-9-enoyl]amino]undecane-1-sulfonic acid

C25H49NO5S (475.3331)


   

(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(undecanoylamino)tetradec-4-ene-1-sulfonic acid

C25H49NO5S (475.3331)


   

(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(pentadecanoylamino)dec-4-ene-1-sulfonic acid

C25H49NO5S (475.3331)


   

3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decane-1-sulfonic acid

3-hydroxy-2-[[(Z)-pentadec-9-enoyl]amino]decane-1-sulfonic acid

C25H49NO5S (475.3331)


   

(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-ene-1-sulfonic acid

(E)-3-hydroxy-2-(tetradecanoylamino)undec-4-ene-1-sulfonic acid

C25H49NO5S (475.3331)


   

(E)-2-(decanoylamino)-3-hydroxypentadec-4-ene-1-sulfonic acid

(E)-2-(decanoylamino)-3-hydroxypentadec-4-ene-1-sulfonic acid

C25H49NO5S (475.3331)


   

(E)-2-(dodecanoylamino)-3-hydroxytridec-4-ene-1-sulfonic acid

(E)-2-(dodecanoylamino)-3-hydroxytridec-4-ene-1-sulfonic acid

C25H49NO5S (475.3331)


   

3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecane-1-sulfonic acid

3-hydroxy-2-[[(Z)-tridec-9-enoyl]amino]dodecane-1-sulfonic acid

C25H49NO5S (475.3331)


   

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C23H42NO7P (475.2699)


   

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C23H42NO7P (475.2699)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (9E,12E,15E)-octadeca-9,12,15-trienoate

C23H42NO7P (475.2699)


   

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (6E,9E,12E)-octadeca-6,9,12-trienoate

C23H42NO7P (475.2699)


   

2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-(butanoylamino)-3-hydroxytetradeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C23H44N2O6P+ (475.2937)


   

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

2-[hydroxy-[(4E,8E,12E)-3-hydroxy-2-(propanoylamino)pentadeca-4,8,12-trienoxy]phosphoryl]oxyethyl-trimethylazanium

C23H44N2O6P+ (475.2937)


   

2-[[(4E,8E,12E)-2-acetamido-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

2-[[(4E,8E,12E)-2-acetamido-3-hydroxyhexadeca-4,8,12-trienoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C23H44N2O6P+ (475.2937)


   

Tubulosine

Tubulosine

C29H37N3O3 (475.2835)


A member of the class of beta-carbolines that is tubulosan bearing methoxy groups at positions 10 and 11 and a hydroxy group at the 8 position.

   

1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

1-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoethanolamine

C23H42NO7P (475.2699)


   

LysoPE(0:0/18:3(6Z,9Z,12Z))

LysoPE(0:0/18:3(6Z,9Z,12Z))

C23H42NO7P (475.2699)


   

(1S,2S,3R,4S,6R)-4-amino-3-[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yloxy]-6-(ethylamino)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside

(1S,2S,3R,4S,6R)-4-amino-3-[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yloxy]-6-(ethylamino)-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside

C21H41N5O7 (475.3006)


   

LysoPE(0:0/18:3(9Z,12Z,15Z))

LysoPE(0:0/18:3(9Z,12Z,15Z))

C23H42NO7P (475.2699)


   

Benzyl n-[(2s)-4-methyl-1-[[(2r)-4-methyl-1-[[(2s)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate

Benzyl n-[(2s)-4-methyl-1-[[(2r)-4-methyl-1-[[(2s)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate

C26H41N3O5 (475.3046)


   

N-hexanoylsphingosine 1-phosphate(2-)

N-hexanoylsphingosine 1-phosphate(2-)

C24H46NO6P (475.3063)


A ceramide 1-phosphate(2-) in which the ceramide N-acyl group is specified as hexanoyl; major species at pH 7.3.

   
   

PE(18:3)

PE(8:0(1)_10:3)

C23H42NO7P (475.2699)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   
   

NA-2AAA 22:4(7Z,10Z,13Z,16Z)

NA-2AAA 22:4(7Z,10Z,13Z,16Z)

C28H45NO5 (475.3298)


   

NA-DOPA 19:1(9Z)

NA-DOPA 19:1(9Z)

C28H45NO5 (475.3298)


   

NA-Phe 22:6(4Z,7Z,10Z,12E,16Z,19Z)

NA-Phe 22:6(4Z,7Z,10Z,12E,16Z,19Z)

C31H41NO3 (475.3086)


   
   
   
   

CerP 14:2;O2/10:0

CerP 14:2;O2/10:0

C24H46NO6P (475.3063)


   
   

ST 25:3;O4;Gly

ST 25:3;O4;Gly

C27H41NO6 (475.2934)


   

ST 26:2;O3;Gly

ST 26:2;O3;Gly

C28H45NO5 (475.3298)


   

ST 19:2;O;HexNAc

ST 19:2;O;HexNAc

C27H41NO6 (475.2934)


   

(4e,8s,9s,10e,12s,13r,14s,16r)-8,14-dimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-1(21),2,4,10,18(22),19-hexaene-3,9,13,20-tetrol

(4e,8s,9s,10e,12s,13r,14s,16r)-8,14-dimethoxy-4,10,12,16-tetramethyl-2-azabicyclo[16.3.1]docosa-1(21),2,4,10,18(22),19-hexaene-3,9,13,20-tetrol

C27H41NO6 (475.2934)


   

4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C27H41NO6 (475.2934)


   

(1r,2r)-2-[(2s,4e,6z,8r,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclobutane-1-carboxylic acid

(1r,2r)-2-[(2s,4e,6z,8r,9s,11r,13s,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]cyclobutane-1-carboxylic acid

C27H41NO6 (475.2934)


   

1-({3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}methyl)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol

1-({3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl}methyl)-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol

C29H37N3O3 (475.2835)


   

(2r,3s,4r,6s)-6-{[(1s,2r,5s,7s,10r,11r,14r,17s,18s)-10,17-dimethyl-16,21-dioxahexacyclo[15.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁸]henicosan-7-yl]oxy}-4-methoxy-2-methyloxan-3-amine

(2r,3s,4r,6s)-6-{[(1s,2r,5s,7s,10r,11r,14r,17s,18s)-10,17-dimethyl-16,21-dioxahexacyclo[15.3.1.0¹,¹⁴.0²,¹¹.0⁵,¹⁰.0¹⁴,¹⁸]henicosan-7-yl]oxy}-4-methoxy-2-methyloxan-3-amine

C28H45NO5 (475.3298)


   

(1r,2s)-2-[(2r,4e,6e,8r,9r,11r,13r,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]-1-methylcyclopropane-1-carboxylic acid

(1r,2s)-2-[(2r,4e,6e,8r,9r,11r,13r,15s,16s)-7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl]-1-methylcyclopropane-1-carboxylic acid

C27H41NO6 (475.2934)


   

3-ethyl-9,10-dimethoxy-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-8-ol

3-ethyl-9,10-dimethoxy-2-{1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-ylmethyl}-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-8-ol

C29H37N3O3 (475.2835)


   

(1s)-1-{[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol

(1s)-1-{[(2s,3r,11bs)-3-ethyl-9,10-dimethoxy-1h,2h,3h,4h,6h,7h,11bh-pyrido[2,1-a]isoquinolin-2-yl]methyl}-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-6-ol

C29H37N3O3 (475.2835)


   

(4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,7r,8s,9s,13z,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C27H41NO6 (475.2934)


   

(4s,7r,8s,9s,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

(4s,7r,8s,9s,16s)-4,8-dihydroxy-5,5,7,9,13-pentamethyl-16-[(1e)-1-(2-methyl-1,3-oxazol-4-yl)prop-1-en-2-yl]-1-oxacyclohexadec-13-ene-2,6-dione

C27H41NO6 (475.2934)


   

2-(7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl)-1-methylcyclopropane-1-carboxylic acid

2-(7-cyano-8,16-dihydroxy-9,11,13,15-tetramethyl-18-oxo-1-oxacyclooctadeca-4,6-dien-2-yl)-1-methylcyclopropane-1-carboxylic acid

C27H41NO6 (475.2934)